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Abstract
Background
Symptom research across conditions has historically focused on single symptoms, and the
burden of multiple symptoms and their interactions has been relatively neglected especially
in people living with HIV. Symptom cluster studies are required to set priorities in treatment
planning, and to lessen the total symptom burden. This study aimed to identify and compare
symptom clusters among people living with HIV attending five palliative care facilities in two
sub-Saharan African countries.
Methods
Data from cross-sectional self-report of seven-day symptom prevalence on the 32-item Me-
morial Symptom Assessment Scale-Short Form were used. A hierarchical cluster analysis
was conducted using Ward’s method applying squared Euclidean Distance as the similarity
measure to determine the clusters. Contingency tables, X2 tests and ANOVA were used to
compare the clusters by patient specific characteristics and distress scores.
Results
Among the sample (N=217) the mean age was 36.5 (SD 9.0), 73.2% were female, and
49.1% were on antiretroviral therapy (ART). The cluster analysis produced five symptom
clusters identified as: 1) dermatological; 2) generalised anxiety and elimination; 3) social
and image; 4) persistently present; and 5) a gastrointestinal-related symptom cluster. The
patients in the first three symptom clusters reported the highest physical and psychological
distress scores. Patient characteristics varied significantly across the five clusters by func-
tional status (worst functional physical status in cluster one, p<0.001); being on ART (high-
est proportions for clusters two and three, p=0.012); global distress (F=26.8, p<0.001),
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Conclusions
The greatest burden is associated with cluster one, and should be prioritised in clinical man-
agement. Further symptom cluster research in people living with HIV with longitudinally col-
lected symptom data to test cluster stability and identify common symptom trajectories
is recommended.
Background
Symptoms are more often clinically presented in advanced stages of HIV [1]. Fatigue, anorexia,
pain, dyspnoea, insomnia, diarrhoea, depression, anxiety and worry each have a prevalence of
at least 50% in advanced HIV [2]. Efficient symptom control is achieved by detailed and regular
symptom assessment.
Clinical research has historically focussed on single symptoms [3]. This over-emphasis on
the study of single symptoms has limited the understanding of the burden of multiple symp-
toms [3]. Recently, clinical research has begun to study the interaction among symptoms [4],
which has led to the use of the term “symptom cluster” to describe a group of three or more re-
lated symptoms [5]. The current evidence provides a large number of studies on symptom clus-
tering in people living with cancer [6]. To date one study has identified symptom clusters in
people living with HIV, and this study did not have the derivation of symptom clusters as its
primary outcome but used data prior to antiretroviral therapy (ART) availability and sought to
establish underlying factors in symptom measurement [7].
Symptom cluster studies are important to inform the management of symptoms to help
lessen the total symptom burden through appropriate treatment plans [6]. For example, symp-
toms belonging to a specific cluster may have a common biological mechanism for which the
treatment of one symptom can result in the alleviation of the other symptoms of that cluster
[8]. Knowledge of symptom clusters can prompt clinical investigation of associated symptoms
when one symptom is detected. There is evidence that this is true for gastrointestinal [9] and
psychological [10] symptoms.
There are two different approaches to conducting a symptom cluster analysis: a clinical and
a statistical one [11]. A clinical symptom cluster analysis approach is used in studies that focus
on a small number of preselected symptoms and they mostly use correlation methods [8]. The
starting point for this type of symptom cluster analysis is clinically observed associations of
symptoms that are likely to cluster such as pain, fatigue, and depression [8]. A statistical ap-
proach is generally applied in studies using multi-symptom assessment tools or symptom
checklists that include a large number of symptoms [8]. The starting point for this type of anal-
ysis is that there is no clinical assumption of symptom associations. Factor or cluster analyses
are used to discover statistically defined symptom clusters. The statistical analysis of multiple
symptoms can identify clusters that may have been overlooked in clinical assessment [6]. For
this reason, statistically derived symptom clusters appear to be more objective than clinical
clusters [6], and may be useful to inform clinical guidelines.
The study and management of symptoms among people living with HIV is essential, as evi-
dence shows that symptom burden is associated with a number of key outcomes [12]. These
are firstly sexual risk taking [13], second poor adherence to ART [14], third treatment
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switching [15], fourth viral rebound [16], fifth poorer quality of life [17], and sixth suicidal ide-
ation [18].
The aim of this study was to employ a statistical cluster analysis technique to identify and
compare symptom clusters among people living with HIV attending five palliative care facili-
ties in two sub-Saharan African countries. The objectives were: 1) to identify clusters of sub-
jects with similar combinations of symptoms; 2) to describe the symptom combinations that
distinguish the clusters; and 3) to compare the clusters with reference to treatment, demo-
graphic and symptom distress related characteristics.
Methods
Study design
This study was part of an international, multicenter, cross-sectional study using the Memorial
Symptom Assessment Scale-Short Form (MSAS-SF) to establish the seven-day prevalence and
associated burden of physical and psychological symptoms of HIV patients receiving palliative
care in sub-Saharan Africa [19].
Setting and sample
The study took place in four palliative care facilities in South Africa and one in Uganda. Pallia-
tive care was provided as home care, day care, hospital consulting, and palliative inpatient ser-
vices, and provide holistic family-based care from diagnosis to the end of life and into
bereavement. Referrals are taken from treatment centres so that palliative care can be provided
alongside ART.
The inclusion criteria for the respondents were: being an adult with a documented HIV pos-
itive sero status according to the health facility records and known to the patient; under pallia-
tive care, and satisfactory physical and cognitive ability to participate in the interviews.
For this analysis HIV patients with a cancer diagnosis were excluded.
Measurement
The MSAS-SF is a 32-tem inventory that assesses the symptoms over a seven-day period preva-
lence. This multidimensional instrument aims to capture the presence and distress of 26 physi-
cal and six psychological symptoms. The associated distress of the 32 symptoms can be scored
on three indices: Physical Symptom Distress Index (MSAS-Phys), Psychological Symptom Dis-
tress Index (MSAS-Psych), and Global Distress Index (MSAS-GDI). These three distress-sub-
scales are scored on a range of 0 (least distressed)- 4 (most distressed). The MSAS-SF possesses
good psychometric properties e.g. subscale Cronbach’s alpha coefficients of 0.76–0.87 indicate
good internal consistency, and there is the proven one-day test-retest reliability correlation co-
efficients of 0.86–0.94 [20]. The MSAS-SF has been regularly applied among African HIV pop-
ulations [21–26].
Research nurses read aloud the MSAS-SF questions and recorded patient responses due to
the potential limited literacy among the respondents, and to reduce bias of mixed completion
methods. As reported in the paper on prevalence from this study [19], all questionnaires were
translated and implemented in local languages (Luganda, Runyankole, SeSotho, Runyoro,
SeTswana, isiXhosa and isiZulu Gauteng and KwaZulu Natal dialects).
Analysis
To describe and conduct our cluster analysis the data of the following variables were extracted:
gender (male/ female); age (continuous variable); being on antiretroviral ART (yes or no);
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physical functional status using the grading of the Eastern Cooperative Oncology Group
(ECOG) scoring system [27] (fully active—restricted—ambulatory—limited self-care—
completed disabled); presence of 32 MSAS-SF symptoms (present/ not present), and the
PSYCH, PHYS and GDI distress scores (least distressed—most distressed).
First we described the sample by country on demographic and symptom data. As it has
been reported in other studies in the region of people living with HIV disease [28], there were
too many missing data for the CD4 count variable, therefore the ECOG was used as a measure
of disease severity. The percentages of the patients with ‘limited self-care’ and ‘completely dis-
abled’ scores were aggregated to represent the most severely physically impaired patients, as
symptoms and ensuing functional impairment are most directly associated with the biological
processes of a disease [29].
To develop an optimum solution, a two-stage sequence of analysis was followed. First, a hi-
erarchical cluster analysis using Ward’s method applying squared Euclidean Distance as the
distance or similarity measure was executed [30]. This helped to determine the optimum num-
ber of clusters to work with. Second, the hierarchical cluster analysis was rerun with the select-
ed number of clusters, which enabled every case to be allocated to a particular cluster.
A hierarchical cluster analysis is a statistical method for finding comparatively homogenous
clusters of cases based on measured characteristics (in this study: the presence of symptoms).
This type of analysis starts with each case as a separate cluster i.e. there are as many clusters as
cases, and then combines the clusters sequentially, reducing the number of clusters at each
step. The clustering method uses the dissimilarities or distances between objects when con-
structing the clusters. To measure the distance between objects, the squared Euclidean distance
measure was selected because it is a measure prescribed to use for dichotomous variables (in
this study symptoms were scored dichotomously recorded only as ‘present’ or ‘not present’). In
comparison to the Euclidean distance measure the squared Euclidean distance measure is used
to place progressively greater weight on objects that are further apart. Ward’s method was used
as the clustering algorithm i.e. the rules that regulate between which point distances are mea-
sured to determine cluster membership. The statistical software SPSS v.19.0 provides five clus-
tering algorithms but Ward’s method was selected because it is a very efficient method, using
an analysis of variance to evaluate the distance between clusters. Cluster membership is ap-
praised by calculating the total sum of squared deviations from the mean of a cluster. The crite-
rion for fusion is that it should produce the smallest possible increment in the error of the sum
of squares [30]. For this study a hierarchical cluster analysis was conducted using three scenari-
os of combinations of four, five and six clusters. The dendrogram of each hierarchical cluster
analysis was evaluated to determine which symptom needed to be allocated to which cluster.
To compare the clusters by patient specific characteristics (sex, being on ART and function-
al status) contingency tables and X2 tests (significance level: p<0.05) were used. To test for dif-
ferences across the clusters on the level of age, GDI, PHY and PSYCH distress scores ANOVA
(significance level: p<0.05) was used. The prevalence of the symptoms in each constructed
cluster was also calculated.
The literature indicates that data on 224 patients are sufficient to conduct a hierarchical
cluster analysis[11] i.e. for the study this meant that the data from the patients from the four
palliative care facilities in South-Africa (177 patients) were merged together with the data from
the patients in the palliative care facility in Uganda (47 patients). Also, including data from two
separate locations improves the inference about the wider population (i.e. people of Africa liv-
ing with HIV/ AIDS who are in palliative care), better than a single location even with the same
sample size. Contingency tables and X2 tests (significance level: p<0.05) and ANOVA (signifi-
cance level: p<0.05) were used to identify significant differences between countries.
The statistical software IBM SPSS Statistics v.19.0 was used for all statistical computations.
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Results
Sample characteristics
The patients in the samples from South-Africa and Uganda are described separately in Table 1.
This table shows that there was no difference in psychological symptom burden, but that physi-
cal symptom burden was slightly higher in South Africa and that this difference is then re-
flected in the global symptom burden.
A cluster analysis was eventually run on 217 cases because there were seven cases missing
from the total sample of 224 cases. Each case responded to items on the presence of 32 symp-
toms that were assessed using the MSAS-SF. This sample of people had a mean age of 36.5
(SD = 9.0) of which 73.2% were female, and 49.1% currently on ART.
Symptom clusters
The hierarchical cluster analysis produced five symptom clusters that fitted (Table 2). Cluster
one included 40 patients, with 45% of them being severely physically impaired (i.e. patients
who have limited self-care to being completely disabled as assessed by ECOG functional status
scale), and it is characterised by symptoms reflecting severe skin problems (i.e. the ‘dermato-
logical-related’ cluster). The second symptom cluster included 46 patients, with 37% of them
being severely physically impaired, and it is characterised by symptoms that indicate the pres-
ence of a general feeling of anxiety together with problems with urinal and faecal elimination
(i.e. the ‘generalised anxiety and elimination’ cluster). The third symptom cluster included 31
patients, with 32% of them being severely physically impaired, and it is characterised by symp-
toms influencing social interactions (including hair loss, mouth sores, swelling of arms or legs,
diarrhoea, problems with sexual interest/ activity, difficulty swallowing, named the ‘social and
image-related’ cluster). The fourth symptom cluster included 70 patients, with 23% of them
being severely physically impaired, and it is characterised by symptoms that can be considered
as persistently present throughout the disease trajectory of people living with HIV e.g. numb-
ness, pain and cough (named the ‘persistently present’ cluster). The fifth symptom cluster in-
cluded 30 patients, with 17% of them being severely physically impaired and it is characterised
by symptoms indicating problems with the gastrointestinal system e.g. nausea and vomiting
(named the ‘gastrointestinal-related’ cluster). In Table 2 all the psychological-related symptoms
are underlined to distinguish them from physical symptoms and highlight their distribution
across the symptom clusters.
Table 2 also demonstrates that patient characteristics varied significantly across the five
clusters by functional status; ART status; global distress subscale, physical distress subscale and
psychological distress subscale. The highest proportion of physically impaired patients as mea-
sured by the ECOG scale were present in symptom cluster one the ‘dermatological related’
(45%), and the lowest proportion were present in cluster five the ‘gastrointestinal related’
symptom cluster (17%) (p<0.001). The highest proportion of patients who were on ART were
present in symptom clusters two ‘generalised anxiety and elimination (63%)’ and three ‘social
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and image-related’ (65%), and the lowest proportion in cluster five the ‘gastrointestinal-related’
symptom cluster (27%) (p = 0.012).
Psychological burden was greatest in clusters one and three (‘dermatological-related’ and
the ‘social aware and image-related’), and lowest in symptom cluster four the ‘persistent pres-
ent’ symptom cluster (F = 21.8, p<0.001). The physical burden was greatest in symptom cluster
one the ‘dermatological related’, and lowest in symptom cluster four the ‘persistent present’
Table 1. Characteristics of HIV+ patients in 4 South-African palliative care facilities (N = 177) and in one palliative care facility in Uganda (N = 47).
Characteristics South-Africa Uganda
Place of receiving
palliative care
At home 70* 53*
Outpatient - 38*
Inpatient 25* -
Day care 5* 9*
Age (mean; S.D.) 36.3; 8.8 36.8; 10.0
Sex: female (%) 77† 60†
On ART (%) 48 53
Functional status: limited self-care/
completely disabled (%)
32† 23†
MSAS-SF symptoms and
prevalence of symptoms:
Difﬁculty concentrating:
33*
Mouth sores: 17 Difﬁculty concentrating:
64*
Mouth sores: 23
Pain: 80† Problems with sexual
interest/ activity: 31*
Pain: 94† Problems with sexual
interest/ activity: 11*
Lack of energy: 71 Itching: 56 Lack of energy: 75 Itching: 70
Cough: 60 Lack of appetite: 41 Cough: 49 Lack of appetite: 41‡
Changes in skin: 51‡ Dizziness: 47† Changes in skin: 64 Dizziness: 64†
Dry mouth: 64‡ Difﬁculty swallowing: 18 Dry mouth: 51 Difﬁculty swallowing: 23
Nausea: 39 Changes in way food
tastes: 28
Nausea: 38 Changes in way food
tastes: 36§
Feeling drowsy/ tired: 75 Weight loss: 60 Feeling drowsy/ tired: 72 Weight loss: 62
Numbness/ tingling in
hands or feet: 66
Hair loss: 25‡ Numbness/ tingling in
hands or feet: 72
Hair loss: 26
Difﬁculty sleeping: 50 Constipation: 32 Difﬁculty sleeping: 47 Constipation: 34
Feeling bloated: 35 Swelling of arms or legs:
27
Feeling bloated: 38 Swelling of arms or legs:
39‡
Problems urinating: 34 “I don’t look myself”: 63* Problems urinating: 30 “I don’t look myself”: 40*
Vomiting: 20 Feeling sad: 76 Vomiting: 28 Feeling sad: 72
Shortness of breath: 40 Worrying: 75‡ Shortness of breath: 26 Worrying: 66
Diarrhoea: 24 Feeling irritable: 74† Diarrhoea: 26 Feeling irritable: 54‡†
Sweats: 55 Feeling nervous: 51 Sweats:60 Feeling nervous: 36
Level of symptom
distress: (mean; S.D)
PSYCH 1.6; 0.9‡ 1.3; 0.9‡
PHYS 1.5; 0.8§* 1.3; 0.7§*
GDI 1.8; 0.8ǁ* 1.4; 0.7§*
Abbreviations: MSAS-SF = Memorial Symptom Assessment Scale-Short Form ART = Antiretroviral Therapy PSYCH = Psychological Symptom Subscale
score PHYS = Physical Symptom Subscale score GDI = Global Distress Index score S.D. = Standard Deviation
*Signiﬁcant at 0.001 level
†Signiﬁcant at 0.05 level
‡Missing value = 1
§Missing value = 2
ǁ Missing value = 3
doi:10.1371/journal.pone.0126554.t001
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Table 2. Characteristics of 5 symptom clusters using hierarchial cluster analysis among HIV+ palliative care patients (N = 217).
Characteristics of each cluster: CLUSTER 1
‘Dermatological-
related’
CLUSTER 2
‘Generalised anxiety
& elimination‘
CLUSTER 3 ‘Social
and image-related’
CLUSTER 4
‘Persistently present‘
CLUSTER 5
‘Gastro intestinal-
related‘
Ranking variable: functional status:
limited self-care/ completely
disabled (%)
45* 37* 32* 23* 17*
Characteristics of
patients in the
cluster:
number of
patients
(n)
40 46 31 70 30
age
(mean; S.
D.)
36.4; 8.6 37.4; 10.1 36.3; 7.5 36.2; 8.8 36.0; 10.3
sex:
female (%)
68.0 71.7 81.0 69.0 83.3
on ART
(%)
45.0† 63.0† 65.0† 47.1† 27.0†
MSAS-SF symptoms and
prevalence of symptoms in the
cluster:
1)itching 70.0 1)feeling
nervous
76.1 1)swelling of
arms or legs
29.0 1)numbness/
tingling in
hands or feet
62.9 1)nausea 13.3
2)pain 61.4
2)dizziness 41.3 3)feeling
irritable
57.1
2)changes
in skin
65.0 3)shortness of
breath
37.0 2)hair loss 25.8 4)cough 52.9 2)vomiting 13.3
4)feeling
bloated
37.0 5)feeling
drowsy/ tired
50.0
5)difﬁculty
concentrating
36.9 3)mouth sores 22.6 6)worrying 45.7
6)difﬁculty
sleeping
32.6 7)dry mouth 44.3 3)lack of
appetite
6.7
8)sweats 41.4
7)problems
urinating
17.4 4)problems with
sexual interest/
activity
22.6 9)feeling sad 40.0
10)lack of
energy
38.6 4)changes
in way food
tastes
3.3
8)constipation 17.4 5)diarrhoea 12.9 11)weight loss 28.6
6)difﬁculty
swallowing
6.5 12)”I don’t look
like myself”
28.6
Level of distress in
MSAS—SF symptom
cluster:
PSYCH
(mean; S.
D.)
2.0; 0.8* 1.8; 0.7* 2.0; 0.7* 0.9; 0.8* 1.6; 0.7*
PHYS
(mean; S.
D.)
2.3; 0.7* 1.7; 0.6*‡ 1.5; 0.7* 0.8; 0.7* 1.2; 0.5*
GDI
(mean; S.
D.)
2.3; 0.7* 2.1; 0.6*‡ 2.1; 0.7* 1.1; 0.7* 1.5; 1.0*
Abbreviations: MSAS-SF = Memorial Symptom Assessment Scale-Short Form ART = Antiretroviral Therapy PSYCH = Psychological Symptom Subscale
score PHYS = Physical Symptom Subscale score GDI = Global Distress Index score S.D. = Standard Deviation
*Signiﬁcant at 0.001 level
†Signiﬁcant at 0.05 level
‡Missing value = 1
doi:10.1371/journal.pone.0126554.t002
Symptom Clusters in People Living with HIV
PLOS ONE | DOI:10.1371/journal.pone.0126554 May 12, 2015 7 / 12
symptom cluster (F = 36.3, p<0.001). The global distress burden was greatest in symptom clus-
ter one the ‘dermatological-related’, and lowest in symptom cluster four the ‘persistent present’
symptom cluster (F = 26.8, p<0.001).
Discussion
The results of this study show that among people living with HIV and receiving palliative care
in five palliative care facilities in two sub-Saharan African countries five distinct statistically de-
rived symptom clusters can be distinguished, with a clear differentiation between clusters.
The data on functional status, ART status, prevalence of the symptoms and the level of
physical and psychological distress in each symptom cluster facilitate the determination of the
relative clinical importance of each. The first three symptom clusters showed the highest level
of distress among the respondents. Firstly, the ‘dermatological-related’ symptom cluster had
the highest level of physical distress and also the highest proportion of physically impaired peo-
ple. This may indicate that the patients belonging to this cluster were in a more advanced stage
of the disease. The frequency of skin disorders increases with progressive immunodeficiency
and may be more severe and respond less well to therapy [1]. The itching and the changes in
skin can be caused by skin infections; skin disorders; hypersensitivity reactions; arthropathy,
HIV polyarthritis, HIV arthropathy, septic arthritis, Reiter’s syndrome, or psoriatric arthritis.
Second, the ‘generalized anxiety and elimination-related’ symptom cluster had the second
highest level of psychological distress and the highest proportion of people currently on ART.
Cluster two could indicate the interaction between physical and psychological related prob-
lems, in that inability to control elimination may cause great distress. This cluster contained
two psychologically related problems with ‘feeling nervous’ presenting with a prevalence of
76.1%. The other six symptoms that were present in the cluster are elimination related prob-
lems e.g. constipation. This cluster could illustrate the debilitating effect of living with an HIV
diagnosis and the associated social, psychological and physical problems. Anxiety is highly
prevalent among people living with HIV [31,32], and should be addressed swiftly, as the evi-
dence states that unaddressed psychological needs have potentially severe clinical implications
such as poor adherence [33].
Third, the ‘social and image-related’ symptom cluster was (together with cluster one) associ-
ated with the highest level of psychological distress. The highest proportion of patients current-
ly on ART was also in this cluster. This cluster is composed of symptoms that influence the
image of a person e.g. hair loss, swelling of arms and legs, and interpersonal problems such as
decreased sexual interest/ activity; mouth sores and difficulty swallowing that would affect eat-
ing. The social dimension of these problems therefore can be easily understood to cause greater
psychological burden, and as ART rollout is increased and HIV is seen as a chronic disease, the
social dimensions of health and wellbeing (and the associated individual burden) must be un-
derstood in the context of continuing stigmatization.
We note several limitations in the interpretation of this novel data. Firstly, while this pro-
vides important new understanding on symptom clustering among HIV/ AIDS patients receiv-
ing palliative care (where the assessment and management of symptoms are most important) it
may not be readily generalizable to all those with HIV disease. Second, as ART is rolled out the
exploration of burden among those on ART may require specific study, as problems have been
shown to persist after treatment initiation [31]. However, given prior global evidence that ART
is not associated with self-report symptom burden [26,34], it was appropriate to include those
both currently taking ART and those who are not, and to determine proportions of these
groups in each cluster. Thirdly, given the unpredictable nature of HIV disease, it is unclear
how stable this symptom clustering is over time, particularly as burden may become greater
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with long time on treatment [35], Fourth, given that we needed to apply the standard exclusion
criterion of cognitive impairment (to avoid any potential bias through mixed self and proxy re-
port), and we excluded those with cancer to make a more readily interpretable cluster structure,
further study is required. Fifth, as CD4 counts were often missing (which is a problem reported
in a similar study in outpatient settings) [28]) data on the physical functional status of the re-
spondents were used as a proxy indicator of the disease progression. Sixth, the cross-sectional
design meant that an evolution of the symptom clusters over time, and whether clusters are sta-
ble could not be determined. Seventh, a replication of the five clusters independently was not
executed. Eighth, a cluster analytical approach does not allow us to understand the etiology of
the clusters.
Conclusion
This is the first study of symptom clusters in HIV/ AIDS patients receiving palliative care using
a cluster analytical approach. Symptom clusters in this patient group could be identified and
these are interpretable. These results also indicate that HIV/ AIDS patients who are on ART
still show a high prevalence of symptoms causing a high level of distress. Given the high preva-
lence of psychosocial problems and stigma reported alongside ART [31], these data also offer
important understanding of the co-existence of physical and psychological problems within
symptom clusters, and therefore the patient must be assessed holistically.
These clusters demonstrate that assessment and treatment planning for symptom clusters
should take account of their physical, psychological and social burden. From clinical and public
health perspectives, assessment and control for people living with HIV are important because
symptom burden is associated with sexual risk taking [13], poor adherence to ART [14], treat-
ment switching [15], viral rebound [16], poorer quality of life [17], and suicidal ideation [18].
These findings are useful for directing assessment and care in clinical practice. The data
demonstrate that patients in symptom cluster one (i.e. the ‘dermatological-related’ symptom
cluster) require the greatest attention to their symptom burden, and that as function declines
their burden is likely to increase.
Future research should investigate symptom clusters in people living with HIV in different
stages of the disease trajectory, and longitudinal study designs may detect changes over time in
symptom cluster constructs.
Importantly, the distress associated with symptom burden should be managed in routine
HIV care.
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